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Abstract 
Background: Antimicrobial peptides (AMPs) are promising candidates for the development of novel antibiotics, but 
it is difficult to produce sufficient quantities for preclinical and clinical studies due to their toxicity towards microbial 
expression hosts. To avoid laborious trial-and-error testing for the identification of suitable expression constructs, we 
have developed a small-scale expression screening platform based on a combinatorial plasmid library.
Results: The combinatorial library is based on the Golden Gate cloning system. In each reaction, six donor plasmids 
(each containing one component: a promoter, fusion partner 1, fusion partner 2, protease cleavage site, gene of inter-
est, or transcriptional terminator) were combined with one acceptor plasmid to yield the final expression construct. 
As a proof of concept, screening was carried out in Escherichia coli and Pichia pastoris to study the expression of 
three different model AMPs with challenging characteristics, such as host toxicity or multiple disulfide bonds. The 
corresponding genes were successfully cloned in 27 E. coli and 18 P. pastoris expression plasmids, each in a one-step 
Golden Gate reaction. After transformation, small-scale expression screening in microtiter plates was followed by AMP 
quantification using a His6 tag-specific ELISA. Depending on the plasmid features and the expression host, the protein 
yields differed by more than an order of magnitude. This allowed the identification of high producers suitable for 
larger-scale protein expression.
Conclusions: The optimization of recombinant protein production is best achieved from first principles by initially 
optimizing the genetic construct. The unrestricted combination of multiple plasmid features yields a comprehensive 
library of expression strains that can be screened for optimal productivity. The availability of such a platform could 
benefit all laboratories working in the field of recombinant protein expression.
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Background
Antimicrobial peptides (AMPs) form part of the innate 
immune system in nearly all living organisms, and they 
act against a spectrum of pathogens including Gram-
positive and Gram-negative bacteria, viruses and fungi. 
These small and often cationic peptides are therefore 
promising candidates for the development of alterna-
tive antibiotics [1]. The identification of a new AMP is 
often followed by chemical synthesis to produce suf-
ficient amounts for initial small-scale functional tests. 
However, structural determination, toxicity testing and 
preclinical studies require larger amounts that cannot be 
produced in a cost-effective manner by chemical synthe-
sis, and heterologous expression is therefore required. 
Heterologous expression is also necessary if the AMP 
is longer than  ~50 amino acids or contains more than 
one disulfide bond [2]. Although recombinant protein 
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expression is inexpensive and scalable, AMPs raise two 
important challenges: first, they are often toxic towards 
microbial expression hosts, and second, they often con-
tain multiple disulfide bonds. One particular expression 
host is therefore unable to fulfill all conditions necessary 
to produce all classes of AMPs.
The bacterium Escherichia coli is widely used as an 
expression host because it is genetically well character-
ized, easy to manipulate, cultivation is simple and inex-
pensive, and there are several decades of experience in 
cloning, process scale-up and automation [3]. However, 
AMPs are often toxic towards E. coli. For example, gly-
cine and proline rich coleoptericins, such as BR021 and 
BR023 from the harlequin ladybird Harmonia axyridis, 
have minimal inhibitory concentrations (MICs) of 63 
and 125  µM, respectively [4, 5]. Similarly, gibberellin 
stimulated-like 1 (GSL1) and the deaminated derivatives 
of other AMPs such as MSI-344 are also toxic towards 
E. coli [6]. Toxic peptides can be produced in E. coli by 
genetic masking using a fusion protein, e.g. thioredoxin 
fusions disrupt the bactericidal activity of GSL1 [7]. 
Toxic peptides can also be expressed as inclusion bodies, 
as shown by the fusion of MSI-334 to PurF [6]. A third 
possibility is the use of specialized E. coli strains such 
as OverExpress C41 (DE3) and OverExpress C43 (DE3), 
which carry mutations making them more tolerant 
towards toxic proteins. SpStrongylocin 1 and 2 could not 
be expressed in E. coli BL21 (DE3), but were successfully 
produced in OverExpress C43 (DE3) [2]. The drawback of 
these strains is that their growth and production rates are 
often lower than in their non-engineered counterparts.
The expression of proteins with multiple disulfide 
bonds in E. coli is also challenging. A suitable model is 
the Galleria mellonella insect metalloproteinase inhibi-
tor (IMPI), which is 69 amino acids in length and con-
tains five disulfide bonds [8]. Two strategies are available 
for the production of such proteins in E. coli. The first 
uses genetically engineered strains with a non-reducing 
cytoplasmic milieu, achieved by mutations in the thiore-
doxin reductase (trxB) and glutathione reductase (gor) 
genes. Such strains include Origami B, Origami 2 and the 
Rosetta-gami B strains from Novagen. They tend to grow 
slowly, but they can successfully express disulfide-rich 
peptides such as Divercin V41 [9]. The second strategy 
involves targeting proteins to the periplasmic space. This 
can be accomplished by adding a signal sequence (e.g. 
from the MalE protein) but the success of this approach 
has been variable, as shown by the expression of 
disulfide-rich venom peptides with 2–6 disulfide bonds 
and lengths ranging from 17 and 67 amino acids [10].
An alternative expression platform that forms disulfide 
bonds naturally is the yeast Pichia pastoris [11]. This spe-
cies is advantageous compared to model yeasts such as 
Saccharomyces cerevisiae because it benefits from pow-
erful inducible promoters and is suitable for high-density 
cultivation. Furthermore, most peptides that are toxic 
towards Gram-negative bacteria such as E. coli are not 
toxic in P. pastoris and vice versa. AMPs that have been 
produced successfully in P. pastoris include snaking-1, a 
63-amino-acid cysteine-rich plant AMP with six disulfide 
bonds [12]; clavanin, a 23-amino-acid α-helical AMP 
that is toxic towards both Gram-positive and Gram-
negative bacteria [13]; and cecropin D, a 3.9-kDa AMP 
that is post-translationally modified [14]. AMP toxicity 
in P. pastoris can also be masked with fusion proteins, so 
including such genetic elements in an expression plas-
mid can have a significant impact on AMP yields. Such 
elements may not only alter AMP expression but also 
facilitate protein detection and purification, which is 
beneficial because downstream processing represents up 
to 80% of recombinant protein production costs. If fusion 
proteins are used, protease cleavage sites for the removal 
of fusion tags must also be included [15].
The optimal genetic setup for each target peptide and 
host is necessary to achieve high yields, and this requires 
the most appropriate combination of promoter, fusion 
protein partner and protease cleavage site. However, the 
rational prediction of optimal combinations is not usu-
ally possible. Expression screening is therefore necessary, 
and must address the following requirements: (1) screen-
ing must be rapid; (2) the procedure must be standard-
ized and independent of the DNA sequence so that the 
same protocol can be used for every new target protein 
without further modifications; and (3) screening should 
be adaptable to different expression hosts, such as E. coli 
and P. pastoris.
Several small-scale expression screening platforms 
have been reported recently [16, 17]. Most comprise 
a pool of pre-assembled (often commercially avail-
able) expression plasmids that carry different promot-
ers, fusion partners, affinity tags and cleavage sites. The 
gene of interest is usually introduced into the plasmids 
by restriction-ligation at a multiple cloning site or by 
homologous recombination. A widely-used example is 
the Gateway® system (Thermo Fisher Scientific) although 
one disadvantage is the limited combination of features 
from a small pool of commercially available plasmids, 
which reduces the number of combinations that can be 
screened. However, for a screening system highly flexible 
expression vectors are required which led to the devel-
opment of combinatorial cloning techniques featuring 
modular expression plasmids [3]. Methods that allow 
the simultaneous assembly of multiple expression plas-
mids from diverse components include restriction-free 
cloning [18], sequence and ligation independent clon-
ing (SLIC) [19, 20], and Golden Gate cloning [21, 22]. 
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Restriction-free cloning and SLIC are based on the poly-
merase chain reaction (PCR). Therefore, custom primers 
must be designed for every new protein of interest and 
additional cloning steps are necessary that are prone to 
mutations. In contrast, Golden Gate cloning does not 
require preparative PCR steps and allows the one-step 
assembly of multiple DNA sequences in a given order 
and orientation [21]. Golden Gate cloning makes use of 
type IIs restriction enzymes such as BsaI that cut at sites 
adjacent to their recognition sequences, allowing the 
selection of any four-nucleotide 5′ overhang for ligation 
and thus the restriction and ligation of multiple DNA 
sequences in a single cloning step (Fig. 1).
Here we describe a straightforward screening plat-
form based on the creation of tailor-made expression 
plasmids by Golden Gate cloning without combinatorial 
limitations [23, 24]. We defined six classes of plasmid 
features that are combined into expression plasmids in 
a single step (Fig. 1): the promoter system, two possible 
fusion partners, the protease cleavage site, the target pro-
tein and the transcriptional terminator. Each expression 
plasmid feature is modular and can be assembled inde-
pendently with every other feature in the correspond-
ing library leaving only a four-nucleotide “scar” between 
elements (or two amino acids in the coding region). The 
modular platform maximizes flexibility for the combina-
tion of conventional and also newly discovered features. 
It will be particularly useful for smaller laboratories 
lacking complex technical equipment such as pipet-
ting robots, but is also suitable for industrial expression 
screening approaches. The platform is universal because 
it can be applied to a broad range of protein types and 
expression hosts. To showcase the platform, we investi-
gated the expression of three model recombinant AMPs 
with different characteristics: (1) IMPI (7.7 kDa; with five 
disulfide bonds) [8]; (2) BR021 (8.4 kDa; toxic towards E. 
coli) [4]; and (3) an antifungal peptide (AFP) from Luci-
lia sericata (8.2  kDa; without disulfide bonds and non-
toxic to our hosts) [25]. We used different promoters and 
fusion proteins to demonstrate their impact on the pro-
tein yield. Expression screening was carried out in differ-
ent E. coli and P. pastoris strains.
Results and discussion
Golden Gate assembly of a basic expression plasmid 
library in E. coli
Figure 1 shows the concept of the Golden Gate plasmid 
library. Six donor plasmids and one acceptor were com-
bined to generate a panel of expression plasmids in a sin-
gle restriction-ligation reaction. The E. coli cloning strain 
NEB10β was then transformed and blue-white screen-
ing was carried out to identify white colonies, which had 
incorporated an expression plasmid. It was necessary to 
optimize the Golden Gate reaction conditions to generate 
Fig. 1 Golden Gate assembly of the expression plasmid in a single reaction. Six donor plasmids and one acceptor plasmid were combined to 
form each expression plasmid by directional cloning in a restriction-ligation step using the endonuclease BsaI and T4 DNA ligase. The overhangs 
produced by BsaI are colored
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the modular plasmid library so the cloning efficiency was 
therefore compared using BsaI-HF and the wild-type 
restriction enzyme BsaI.
The proportion of white colonies after transformation 
was considerably higher when we used the wild-type 
enzyme BsaI (97%) rather than BsaI-HF (31%). The better 
performance of the wild-type enzyme may be caused by 
its full activity at 50  °C during the final restriction step, 
in contrast to the depleted activity of BsaI-HF (NEB, per-
sonal communication). This step is necessary for the effi-
cient digestion of residual acceptor plasmids because any 
remaining acceptor plasmids in the mixture produce blue 
colonies.
Using the established Golden Gate assembly pro-
cess, a plasmid library was constructed to express the 
three peptides of interest: IMPI, BR021 and AFP (Fig. 2). 
Three different promoters (T7/lac, T5/lac and araBAD) 
were combined with glutathione-S-transferase (GST) or 
thioredoxin (Trx) as fusion partners (or with no fusion 
partner). The three promoters were chosen because of 
their different strengths. The T7/lac promoter is a strong 
promoter and may therefore lead to the highest total 
protein yields. On the other hand, a strong promoter 
like T7/lac is associated with a higher risk of inclusion 
body formation [26] and is therefore not always the best 
choice when soluble expression is desired. All constructs 
contained an N-terminal His6 tag to facilitate detection 
and purification. The plasmids incorporating fusion part-
ners also contained an additional thrombin cleavage site. 
We chose thrombin for cleavage because it is cheap and 
therefore suitable for large scale purification. The T7 
transcriptional terminator was used in all plasmids. This 
generated a potential total of 27 expression plasmids, 18 
of which contained all six elements.
For 17 of the 18 constructs ≥1 clone with correct band 
pattern was identified in a colony PCR analysis based on 
eight white colonies. The remaining plasmid (T5 pro-
moter, thioredoxin and AFP) was detected after a second 
PCR run testing seven more colonies, which resulted in 
two hits. For all assemblies, we determined the propor-
tion of white colonies and the proportion of colonies 
testing positive by colony PCR (Fig.  3a, b). The overall 
cloning efficiency was then calculated as the product of 
the proportion of white colonies multiplied by the pro-
portion of colonies testing positive by colony PCR (Eq. 1):
Sequencing confirmed the positive events identified by 
colony PCR, so no further calculations were needed to 
describe the overall cloning efficiency. There was also no 
significant deviation in the cloning efficiency when using 
different promoters, fusion partners and target proteins 
(Fig. 4a–c). The Golden Gate assembly therefore appears 
to be a robust method regardless of the sequences of the 
individual plasmid features.
However, the cloning efficiencies achieved above 
could not be reproduced during the assembly of the 
nine expression plasmids lacking the fusion partner and 
protease cleavage site. To fill the gaps, we initially used 







positive in colony PCR
number of colony PCR samples
Fig. 2 Basic plasmid library for E. coli. The plasmid library consists of 13 donor plasmids, resulting in 27 different expression plasmids. Three promot-
ers (T7/lac, T5/lac and araBAD) were combined with a His6 tag and either GST or Trx as a fusion partner (or no fusion partner). A thrombin cleavage 
site was also included in the constructs with a fusion partner. The library includes three AMP genes encoding IMPI, BR021 or the L. sericata antifun-
gal peptide (AFP). The T7 transcriptional terminator was present in all constructs. The chosen BsaI overhangs are shown above the elements
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flanked by the appropriate BsaI recognition sites and 
overhangs. The cloning efficiencies of the expression 
plasmids containing two consecutive dummy fragments 
were poor (Fig.  4d; His-empty-empty). Therefore, three 
of the nine plasmids could not be assembled using the 
standard procedure, including the analysis of eight white 
colonies by colony PCR. This phenomenon may reflect 
the length of the dummy fragments. Because the frag-
ments consist solely of the flanking overhangs and two 
additional base pairs, they are present as single strands 
under our reaction conditions (16  °C for ligation and 
37 °C for restriction). Equation 2 can be used to calculate 
the melting temperature (TM) of short DNA molecules 
in solution, and this suggests that the dummy fragments 
have a TM of 12 °C.
Despite the low cloning efficiency, positive clones were 
usually identified by increasing the number of colonies 
screened by PCR. Alternatively, when a special combina-
tion of fragments such as “His-empty-empty” is required 
more frequently, a workaround strategy can be used in 
which a combined fragment is introduced as an addi-
tional donor plasmid, e.g. His6 with BsaI overhangs com-
plementary to the promoter system on one side and to 
the target protein on the other side. This workaround sig-
nificantly increased the cloning efficiency (Fig.  4d; His-
bridge) and the three expression plasmids that could not 
be assembled using the dummy donor plasmids based on 
the screening of eight white colonies were cloned suc-
cessfully using this approach.
Golden Gate assembly of a basic expression plasmid 
library in P. pastoris
A second plasmid library was created in P. pastoris to 
achieve the expression and secretion of the peptides 
IMPI, AFP and BR021 (Fig.  5). This library combined 
two different promoters (the glyceraldehyde-3-phosphate 
dehydrogenase promoter pGAP and the alcohol oxidase 
I promoter pAOXI) with three different secretion factors 
(the α-mating factor, the same factor with an additional 
serine endoproteinase cleavage site (Kex2), and the secre-
tion factor of a protein containing four tandem DDDK 
sequences). Each construct also contained a His6 tag to 
facilitate detection, a split intein for purification, and 
finally the transcriptional terminator from the alcohol 
oxidase I gene (tAOXI). All 18 expression plasmids were 
successfully generated by Golden Gate cloning followed 
by the transformation of E. coli and colony PCR analysis 
of eight white colonies. Figure 6 shows the cloning results 
in detail.
Comparison of cloning efficiencies for E. coli and P. pastoris
The average percentage of white colonies was 37 ± 30% 
for the E. coli constructs and 5 ± 2.6% for the P. pastoris 
constructs. The average percentage of colonies displaying 
the anticipated band pattern following colony PCR analy-
sis was 69 ± 35% for the E. coli constructs and 87 ± 13% 
for the P. pastoris constructs. The cloning efficiencies we 
observed were therefore lower than those reported by 
Engler et  al. [22] using a similar protocol and the same 
BsaI overhangs (99% white colonies and 94% colonies 
with the correct restriction pattern). The difference in 
cloning efficiency is therefore likely to be caused by the 
genetic elements we used, and can potentially be attrib-
uted to the vast difference in size between the genetic 
(2)TM = (A+ T) · 2 ◦C + (G+ C) · 4 ◦C + 8 ◦C
Fig. 3 Proportion of white colonies and PCR-positive white colo-
nies after the Golden Gate assembly of different E. coli expression 
plasmids. a The proportion of white colonies was determined in a 
blue-white screening assay. The proportion of white colonies varied 
according to which plasmid features were used. For each assembly, 
eight white colonies were analyzed by colony PCR. b The proportion 
of analyzed colonies with a PCR product of the correct size
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Fig. 4 Cloning efficiencies for the Golden Gate assembly of different E. coli expression plasmids. Each dot represents one cloning procedure with an 
individual expression plasmid. There were no significant differences in the cloning efficiencies of the different promoters (a), fusion partners (b) or 
proteins (c). d Shows the cloning efficiencies for an expression plasmid where two consecutive plasmid features were left out, here the fusion part-
ner and the protease cleavage site. In this case, Golden Gate cloning using two short dummy fragments was compared to a workaround strategy 
in which one of the neighboring plasmid feature sequences (here for the His6 tag) carries a BsaI overhang directly complementary to the plasmid 
feature “protein of interest” so that no short dummy fragments are needed. As a comparison, the cloning efficiencies for the assembly of the other 
18 expression plasmids, which carry all six classes of plasmid features, are also shown
Fig. 5 Basic plasmid library for P. pastoris. The plasmid library consists of 11 donor plasmids, resulting in 18 different expression plasmids. Two 
promoters (pGAP and pAOXI) were combined with three secretion factors (the α-mating factor, Kex2, DDDK), a His6 tag and an intein sequence. The 
tAOXI transcriptional terminator was present in all constructs
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elements (T5/lac promoter: 1311  bp, His6 tag element: 
21 bp) compared to the genetic elements used by Engler 
et  al. which had all nearly the same size [22]. However, 
further investigations on this topic have to be done. Nev-
ertheless, all 45 expression plasmids were cloned and ver-
ified by sequencing within 2 weeks, which confirms that 
the method is rapid and robust enough for our purpose.
Expression screening in E. coli
The 27 expression plasmids assembled by Golden Gate 
cloning were used to screen for the optimal expression 
of IMPI, BR021 and AFP. Six E. coli expression strains 
with different characteristics were used. Rosetta-gami 2 
(DE3) pLysS, Origami 2 and SHuffle T7 Express lysY are 
strains with an oxidizing milieu in the cytoplasm and 
were therefore selected for the expression of IMPI with 
its five disulfide bonds. OverExpress C41 (DE3) pLysS 
and OverExpress C43 (DE3) pLysS are strains that are 
suitable for the expression of toxic proteins [27] and were 
therefore chosen for the expression of BR021. The stand-
ard expression strain BL21 (DE3) was also included. We 
developed a small-scale screening approach suitable for 
any laboratory without pipetting robots and automa-
tion, which involved the rational selection of the two or 
three most promising strains for every expression plas-
mid (78 combinations). For two of these combinations 
the transformations failed, resulting in 76 viable combi-
nations. A possible explanation for the failure of the two 
transformations could be the instability of the plasmids 
in the corresponding strains. In this case the combina-
tions will not be useful for protein expression and can 
be excluded from the screening. Screening was carried 
out in 96-well microtiter plates. The cultures were grown 
from OD600 = 0.1 for 3 h at 37 °C, followed by the induc-
tion of protein expression and incubation for 17  h at 
30 °C. Protein yields in the soluble fraction after cell lysis 
were determined by a sandwich ELISA using the His6 tag 
to identify the high producers.
As shown in Fig. 7, all IMPI high producers (yields of 
soluble IMPI  >  10  mg/Lculture) carried Trx as the fusion 
partner, whereas the yields were lower with GST as the 
fusion partner and lower still when the fusion tag was 
omitted. Similar results were reported previously for the 
comparison of Trx + His6, GST + His6 and the His6 tag 
alone [28]. The solubility-enhancing effect of the fusion 
partner was previously shown to depend on the size of 
the target protein and is most prominent for small pro-
teins [29], which explains the substantial effect of fusion 
partners on the yield of the small (7.7 kDa) target protein 
IMPI. The promoter had a strong effect on expression as 
expected, and the inducible T7/lac promoter resulted in 
the greatest improvement in the yield of IMPI as previ-
ously noted in a study comparing the T7/lac and the 
araBAD promoters among others [30]. In contrast, we 
found that the expression strain had only a minor effect 
on the yield of IMPI.
For the toxic protein BR021, only one strain achieved 
a significant production level, highlighting the need for a 
screening strategy when dealing with difficult-to-express 
proteins. BR021 was successfully expressed in the stand-
ard expression strain BL21 as a Trx-fusion protein under 
the control of the T7/lac promoter system. Interestingly, 
only low yields were achieved in OverExpress C41 and 
C43 although these strains are specialized in the expres-
sion of toxic proteins in E. coli. To exclude the possibility 
of a false-positive result, BR021 expression using strain 
Fig. 6 Portion of white colonies and PCR-positive white colonies 
after the Golden Gate assembly of different P. pastoris expression 
plasmids. a The proportion of white colonies was determined in a 
blue-white screening assay. The proportion of white colonies varied 
according to which plasmid features were used. For each assembly, 
eight white colonies were analyzed by colony PCR. b The proportion 
of analyzed colonies with a PCR product of the correct size
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BL21 with the T7/lac + Trx combination was repeated 
in shaking flasks. Quantification of the soluble and insol-
uble protein fractions revealed that the majority of the 
target protein was present as insoluble inclusion bodies 
and only a small amount of soluble protein was present 
(Additional file 1). It is likely that the protein detected in 
the soluble fraction was only solubilized during cell lysis. 
Because the yield of insoluble protein was extremely 
high (~0.6  g/Lculture) we will investigate the purifica-
tion of Trx-BR021 from the inclusion bodies in future 
experiments.
The maximum yield of L. sericata AFP (4.2 ± 0.5 mg/
Lculture) was achieved in BL21 cells as a GST-fusion pro-
tein under the control of the T7/lac promoter. The 
successful expression of this AFP in E. coli BL21 (DE3) 
cells has previously been achieved using an N-terminal 
Trx-His6 tag [25].
Expression screening in P. pastoris
Pichia pastoris was used as an alternative expression 
host in our screening platform because it is ideal for pro-
teins that are too toxic or complex for production in E. 
coli. Expression was facilitated by including its two best-
characterized promoter systems: the methanol-inducible 
pAOXI promoter, which is strictly regulated and allows 
the production of toxic proteins, and the constitutive 
pGAP promoter, which allows the application of simpler 
fermentation conditions [31].
Fig. 7 Expression screening in E. coli. Expression screening was carried out in 96-well microtiter plates to identify high producers for three different 
target proteins. The promoter, protein fusion partner and E. coli strain were varied. a IMPI, b BR021, c AFP. Rosetta-gami 2 Rosetta-gami 2 (DE3) pLysS, 
Origami Origami 2, SHuffle SHuffle T7 Express lysY, BL21 BL21 (DE3), C41 OverExpress C41 (DE3) pLysS, C43 OverExpress C43 (DE3) pLysS
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Pichia pastoris secretes recombinant proteins into the 
fermentation broth if an appropriate secretion signal is 
included in the construct, thus facilitating protein puri-
fication. A protease cleavage site is also needed, to allow 
the recovery of the native protein without the signal 
sequence. We therefore combined the three AMPs with 
three different secretion factors (Fig. 5):
1. The α-mating factor [32]. This is one of the most 
widely used secretion factors, but in vivo processing 
can lead to the fragmentation of peptides that have 
internal accessible KR or RR dibasic amino acids.
2. The DDDK secretion factor [33]. This 18-amino-
acid secretion factor was identified recently [33] and 
secrets a P. pastoris protein containing four DDDK 
tandem repeats. The α-mating factor and DDDK 
achieved similar secretion efficiency when tested 
with porcine carboxypeptidase and the Erythrina caf-
fra trypsin inhibitor.
3. The α-mating factor with an additional Kex2 protease 
site [34]. Some proteins are secreted with low effi-
ciency by the α-mating factor because the Kex2 site 
is inaccessible, and this can be addressed by adding a 
second site for the Kex2 protease.
To facilitate the removal of the fusion protein, we 
incorporated self-splicing inteins in the P. pastoris system 
rather than the classical thrombin cleavage site used in E. 
coli. Furthermore we investigated two different produc-
tion strains: the X-33 wild-type strain and the SuperMan5 
strain (HIS+, pep4Δ) in which selected peptidases are 
knocked out. After successful cloning using the Golden 
Gate system as described above, the two P. pastoris 
strains were transformed with the expression plasmids 
by electroporation. Whereas protein expression in E. coli 
is usually based on an episomally-maintained plasmid 
under constant selection, in P. pastoris the plasmid inte-
grates into the genome and no selection is necessary dur-
ing fermentation. Although integration is site-specific, 
the number of integrated copies is random and we there-
fore screened eight clones for each expression construct.
Expression in 96-deep-well plates was followed by 
His6 tag-specific ELISA to determine the AMP yields. 
We found that BR021 was not expressed at all, and only 
one clone was isolated expressing the L. sericata AFP 
but the yield was very low (0.17  mg/Lculture). This clone 
comprised the constitutive pGAP promoter combined 
with the Kex2 secretion factor element in the SuperMan5 
strain. The low yields of BR021 and AFP probably reflect 
the presence of proteases such as proteinase A (PrA) 
and proteinase B (PrB) [35], or they may not be properly 
secreted despite the presence of a secretion factor in the 
construct. In contrast, IMPI was expressed successfully 
by P. pastoris (Fig.  8). Only the DDDK secretion factor 
was incompatible with the expression of this peptide, 
whereas the α-mating factor achieved efficient secre-
tion in the presence and absence of the additional Kex2 
site. IMPI was successfully expressed in both P. pastoris 
strains under the control of the constitutive pGAP pro-
moter, but only in strain X33 under the inducible pAOXI 
promoter. The highest yield was achieved with the pGAP 
promoter and Kex2 as the secretion signal in the Super-
Man5 strain (1.7 mg/Lculture).
Comparison of expression screening in E. coli and P. 
pastoris
Expression screening in E. coli and P. pastoris achieved 
different outcomes for the three model AMPs. For 
BR021, expression as a soluble peptide was not pos-
sible, at least not with the genetic elements and strains 
we used. E. coli appears to be the most suitable expres-
sion host, and the purification of BR021 from inclusion 
bodies appears to be the most appropriate expression 
strategy. The L. sericata AFP could not be expressed at 
significant levels in either E. coli or P. pastoris, indicating 
that the screening platform must be expanded to include 
more genetic elements, additional strains or even further 
expression hosts. IMPI was expressed at high levels in 
both E. coli and P. pastoris, with yields depending on the 
strain and plasmid combination. We identified genetic 
elements compatible with high expression levels, e.g. the 
T5 and T7 promoter as well as Trx as fusion partner in 
E. coli, and the α-mating factor with or without the addi-
tional Kex2 site in P. pastoris. In a direct comparison, E. 
coli achieved higher IMPI yields than P. pastoris at the 
small screening scale using the combination of plasmid 
features we tested. However, large-scale and high-cell-
density fed-batch or continuous fermentation tests would 
be necessary to determine which expression system is 
better for the respective AMP.
Conclusions
Antibiotic-resistant bacteria are becoming more preva-
lent, and the demand for new classes of antimicrobial 
drugs is therefore increasing. Insect AMPs are promis-
ing candidates but the first challenging step is the het-
erologous expression of sufficient quantities of AMPs 
for preclinical and clinical studies. AMPs have diverse 
characteristics and expression screening is therefore nec-
essary to identify the optimal combination of expression 
construct and host to achieve high yields. We developed 
a screening platform based on a combinatorial plas-
mid library, and screened for the optimal expression of 
three model AMPs in two hosts: E. coli and P. pastoris. 
Our results highlight the importance of screening before 
further process optimization, because different outcomes 
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were observed for each AMP. IMPI was successfully 
expressed using different plasmid/strain combinations 
in both E. coli and P. pastoris and can now be produced 
at larger scales, whereas BR021 could only be expressed 
as insoluble inclusion bodies in E. coli and the L. sericata 
AFP could not be expressed using any of our strain/plas-
mid combinations. The latter case shows the limitations 
of small-scale screening with a limited number of com-
binations—it is possible that no hits will be achieved and 
subsequent larger screens may be necessary incorporat-
ing additional plasmids, strains and even host organisms. 
Our screening platform can be expanded to encompass 
additional hosts with little further effort, potentially 
including insect cells because they are more closely 
aligned with the native production of insect AMPs [36], 
and alternative yeasts such as Kluyveromyces lactis [37]. 
We are convinced that the platform will also be useful for 
larger proteins (>10 kDa), because Golden Gate cloning 
has been shown to work for DNA fragments up to at least 
3500 bp [38] and the screening itself relies on simple cul-
tivation in a 96-well plate followed by protein quantifica-
tion using a His6-specific ELISA, which is a method that 
is commonly used for proteins of all sizes.
Methods
Cultivation of P. pastoris and E. coli
Unless stated otherwise, all culture media and ingredi-
ents for screening in P. pastoris were prepared accord-
ing to the protocol from the Pichia Protein Expression 
Kit [39], although we replaced the BMGY medium with 
BMDY medium (containing glucose instead of glycerol).
Escherichia coli was cultivated in standard LB medium 
containing 10 g/L tryptone, 5 g/L yeast extract and 10 g/L 
NaCl at pH 7.0 (Carl Roth).
Constructs
The donor plasmid was derived from the commercial 
plasmid pJ915 (DNA2.0) and contains an ILV5 pro-
moter, an EM72 promoter, a bleocin-resistance cassette, 
the AOD terminator, the pUC origin of replication and 
a lacZ cassette. The plasmid features were synthesized 
by GenScript. GenScript used the PciI restriction site in 
plasmid pUC57-Kan as a cloning site to insert the plas-
mid features into the vector. The DNA sequences for the 
plasmid features were flanked by BsaI recognition sites 
to allow directional cloning. Two extra base pairs were 
added upstream of the DNA sequences for the protein 
fusion partners, protease cleavage sites and AMP genes 
to avoid frameshifts. The four-nucleotide BsaI overhang 
sequences were adopted from Engler et  al. [22] (Fig.  2). 
The synthesized donor plasmids were used directly for 
Golden Gate cloning.
Golden Gate cloning
Each Golden Gate cloning reaction required 100  ng of 
the acceptor plasmid (pJ915-lacZ), 100 ng of each donor 
plasmid, 2.5 U BsaI/BsaI-HF and 300 U T4 DNA ligase 
(NEB, 2000 U/µL) in a reaction mixture of 15 µL in 1× 
T4 DNA ligation buffer (NEB). The reactions comprised 
50 temperature cycles (2 min at 37 °C for digestion, 5 min 
at 16 °C for ligation) followed by 10 min final restriction 
at 50 °C and 20 min heat inactivation at 65 °C.
After the Golden Gate reaction, chemically competent 
E. coli 10-beta (NEB) cells were transformed with the 
reaction mix using the following heat shock protocol. 
First 80 µL of cells were thawed on ice and 5 µL of reac-
tion mix were added. Afterwards the mix was incubated 
on ice for 15 min. Then a heat shock at 42 °C for 1 min 
was done. Afterwards 250  µL LB medium were added 
Fig. 8 Expression screening for IMPI production in P. pastoris. Expres-
sion screening was carried out in 96-well microtiter plates to identify 
high producers. The secretion factor was varied in the screening and 
eight different clones for each combination were screened. a pGAP, 
b pAOXI
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and the cells were incubated at 600  rpm and 37  °C for 
45 min. Transformants were plated on selective LB agar 
plates containing either 15 µg/mL gentamicin or 10 µg/
ml Bleocin™, 1  mM IPTG and 100  µg/mL X-Gal for 
blue–white screening. After incubation for 1 day at 37 °C, 
the blue and white colonies were counted.
Eight colonies per construct were analyzed by colony 
PCR using primers that bind to the acceptor plasmid 
backbone. Colony PCR was carried out using OneTaq 
DNA Polymerase (NEB) following the manufacturer’s 
protocol. Plasmid DNA was isolated from colonies with a 
correct colony PCR band pattern using the NucleoSpin® 
Plasmid EasyPure kit (Macherey–Nagel). The DNA was 
sequenced by GATC biotech with the same primers used 
for colony PCR.
Transformation of E. coli expression strains
Six different E. coli strains were used for expression 
screening: Rosetta-gami 2 (DE3) pLysS (Merck Mil-
lipore), Origami 2 (Merck Millipore), BL21 (DE3) (NEB), 
SHuffle T7 Express lysY (NEB), OverExpress C41 (DE3) 
pLysS (Sigma-Aldrich), OverExpress C43 (DE3) pLysS 
(Sigma-Aldrich). E. coli expression strains were trans-
formed with the expression plasmids by heat shock. 
An 80-µL aliquot of competent cells was thawed on ice 
before adding 5  µL of the Golden Gate mixture. The 
cells and DNA were incubated for 15  min on ice and 
heat shocked for 1  min at 42  °C. After the heat shock, 
250 µL LB medium was added to the transformants and 
the mixture was incubated for 45 min at 37 °C, shaking at 
1100 rpm in a thermomixer (Eppendorf ). After the incu-
bation, 50 µL of the cell mixture was spread on LB agar 
containing 15 µg/mL gentamicin.
Prior to expression screening, cryocultures were pre-
pared from overnight liquid cultures grown in LB con-
taining 15 µg/mL gentamicin at 37 °C and 250 rpm. Cells 
from overnight cultures were harvested by centrifuga-
tion, resuspended in LB containing a final concentration 
of 25% (v/v) glycerol and frozen at −80 °C for storage.
Transformation of P. pastoris expression strains
Competent P. pastoris (SuperMan5 or X33) cells were 
transformed essentially as previously described [40, 41] 
but using 100 ng DNA linearized by enzymatic digestion 
with BspHI (according to the NEB protocol) followed by 
DNA purification (NucleoSpin® Plasmid EasyPure Kit, 
Macherey–Nagel). After transformation by electropo-
ration the cells were spread on YPD plates containing 
10 µg/mL bleocin (Merck Millipore) and were incubated 
for 3 days at 30 °C. Eight colonies representing each con-
struct were then transferred to a new plate containing the 
same medium.
Expression screening in E. coli
Expression screening was carried out in 96-well plates 
(Eppendorf ). Each well contained 300  µL LB medium 
plus 15 µg/mL gentamicin and was inoculated with over-
night cultures of E. coli transformants to yield an OD600 of 
0.1. The space between the wells was filled with water and 
the plate was sealed with Parafilm to minimize evapora-
tion. The cells were cultivated in a plate reader (Biotek) 
at 37  °C for 3  h with linear shaking at 567  cpm and an 
amplitude of 3 mm. Absorption at 600 nm was measured 
online every 20  min to monitor cell growth. After 3  h, 
protein expression was induced by adding 1 mM IPTG or 
13 mM arabinose, depending on the promoter. The culti-
vation temperature was lowered to 30 °C during the 17-h 
protein expression phase. Cells were harvested by cen-
trifugation and lysed with BugBuster Master mix (Merck 
Millipore) following the manufacturer’s protocol. Lysates 
were stored at 4 °C. Proteins in the cell lysates were quan-
tified by a His6 tag-specific sandwich ELISA using the His 
Tag Antibody Plate (GenScript) following the manufac-
turer’s protocol. Samples were diluted 1:100. Penta∙His 
HRP Conjugate (Qiagen) was diluted 1:4000 and was 
used as the detection antibody. The amount of target 
protein was calculated using a dilution series of His6 tag 
human ephrin-B1 (Sino Biological) for calibration.
Expression screening in P. pastoris
Constitutive and methanol induction screening were 
carried out as previously described [42] but instead of 
humidity control, a double layer of Parafilm was added 
between the lid and the 96-deep-well plate. The starting 
volume was 500 µL of BMY medium containing 1% glu-
cose. For the feed, the cells were pipetted up and down 
thoroughly to ensure good mixing and 125  µL medium 
was then removed and replaced with 125 µL fresh BMY 
medium containing 4% glucose every 24 h, making four 
replacements in total. Twenty-four hours after the last 
feed, the supernatant was harvested by centrifugation 
(10,000×g, 5  min) and 200  µL supernatant (undiluted) 
was used for protein quantification by a His6 tag-specific 
sandwich ELISA as described for E. coli.
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